Recent News

• 03.11.2025 - iCAD to Report Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025
• 03.05.2025 - iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America
• 02.26.2025 - Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025
• 02.19.2025 - iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025
• 01.27.2025 - iCAD Pre-Announces Estimated Q4 2024 Revenue
• 12.11.2024 - RSNA 2024: Transforming Breast Health through AI
• 12.11.2024 - SABCS 2024: New Research Assesses iCAD’s Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations

Recent Filings

• 02.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.27.2025 - EX-99.1 EX-99.1
• 01.27.2025 - 8-K Current report
• 01.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.07.2025 - 4 Statement of changes in beneficial ownership of securities